share_log

UBS Initiates Coverage On Celestica With Neutral Rating, Announces Price Target of $95

UBS Initiates Coverage On Celestica With Neutral Rating, Announces Price Target of $95

瑞银开始对天弘科技进行覆盖,给出中立评级,并宣布目标价格为95美元。
Benzinga ·  2024/11/22 08:04  · 评级/大行评级

UBS analyst David Vogt initiates coverage on Celestica (NYSE:CLS) with a Neutral rating and announces Price Target of $95.

瑞银分析师戴维·沃格特以中性评级开始对Celestica(纽约证券交易所代码:CLS)进行报道,并宣布目标股价为95美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发